Friday, February 22, 2019
Home Tags Rare Diseases

Tag: Rare Diseases

Exploring mucopolysaccharide storage disorders

Exploring mucopolysaccharide storage disorders

The New Modalities Ecosystem: a much-needed boost for rare diseases

The New Modalities Ecosystem: a much-needed boost for rare diseases

Patient groups: our strongest weapon against rare diseases

Patient groups: our strongest weapon against rare diseases

Fit for purpose? The European Reference Networks, two years on

Fit for purpose? The European Reference Networks, two years on

Female scientist conducting experiment

Rare diseases in the Finnish landscape

Therapies for recombination-deficient severe combined immunodeficiency

Therapies for recombination-deficient severe combined immunodeficiency

Uterine sarcoma – tackling the rare aggressive cancer

Uterine sarcoma – tackling the rare aggressive cancer

Becoming reality – mucopolysaccharide storage diseases and adulthood

Becoming reality – mucopolysaccharide storage diseases and adulthood

A call to action for idiopathic pulmonary fibrosis

A call to action for idiopathic pulmonary fibrosis

Rare blood disorders: could sutimlimab treat the untreatable?

Rare blood disorders: could sutimlimab treat the untreatable?

Nosocomial infections: the potential killer Staphylococcus epidermidis

Nosocomial infections: the potential killer Staphylococcus epidermidis

Study reveals how aid communication is perceived in African countries

Study reveals how aid communication is perceived in African countries

1234Page 1 of 4

Health Special Reports

Health eBooks

Health Partners

Latest Special Reports

Latest eBooks

Latest Publications

© Pan European Networks Ltd

Pin It on Pinterest

UK OFFICE: +44 (0)1260 273 802
© 2018 - Published by Pan European Networks Ltd in Congleton, United Kingdom. - Co. Reg. No: 7652562
Disclaimer: www.healtheuropa.eu is an independent portal and is not responsible for the content of external sites.
Please Note: Phone calls may be recorded for training and monitoring purposes.